Nomura Holdings’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-27,100
Closed -$2.62M 1951
2024
Q1
$2.62M Buy
+27,100
New +$2.78M 0.01% 835
2019
Q2
Sell
-70,085
Closed -$6.01M 1269
2019
Q1
$6.01M Buy
+70,085
New +$5.63M 0.03% 412
2016
Q4
Sell
-89,280
Closed -$6.32M 1621
2016
Q3
$6.32M Hold
89,280
0.02% 384
2016
Q2
$6.55M Buy
+89,280
New +$6.17M 0.02% 368
2015
Q1
Sell
-223,200
Closed -$18.5M 2126
2014
Q4
$18.5M Sell
223,200
-418,500
-65% -$34.7M 0.05% 231
2014
Q3
$54.1M Buy
641,700
+27,900
+5% +$2.26M 0.15% 122
2014
Q2
$49.6M Sell
613,800
-390,600
-39% -$30.7M 0.01% 157
2014
Q1
$76.1M Buy
+1,004,400
New +$73.2M 0.02% 101

Other funds holding NVS

Nomura Holdings's NVS Position: Q2 2026 in Review

Nomura Holdings reduced its Novartis (NVS) stake by 5.1% in Q2 2026, selling an estimated $750K and leaving 94,009 shares worth $14.7M. The position accounts for 0.02% of the portfolio, ranked #443.

Nomura Holdings first reported a position in NVS in Q3 2013 and has held it in 12 quarters since. The position peaked at $15.1M in Q1 2026. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Nomura Holdings held 94,009 shares of Novartis worth $14.7M as of Q2 2026.
  • Nomura Holdings sold 5,004 Novartis shares in Q2 2026, an estimated $750K.
  • Novartis made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #443 holding.
  • Nomura Holdings first reported a position in Novartis in Q3 2013 and has held it in 12 quarters since.
  • Nomura Holdings's Novartis position peaked at $15.1M in Q1 2026.
  • 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.